Cephalon (UK) Limited

1 Albany Place, Hyde Way, Welwyn Garden City, Hertfordshire, AL7 3BT
Telephone: +44 (0) 1707 385800
Fax: +44 (0) 1707 385801
WWW: http://www.cephalon.co.uk
Medical Information Direct Line: 0800 783 4869
Medical Information e-mail: ukmedinfo@cephalon.com
Medical Information Fax: +44 (0) 1707 385802

Patient Information Leaflet last updated on the eMC: 16/12/2011
PIL Dopacard

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 16/12/2011 and displayed until Current
Reasons for adding or updating:
  • Change to information for healthcare professionals
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change to dosage and administration
Updated on 26/04/2010 and displayed until 16/12/2011
Reasons for adding or updating:
  • Change of manufacturer
Updated on 14/09/2009 and displayed until 26/04/2010
Reasons for adding or updating:
  • Change of manufacturer
Updated on 27/08/2008 and displayed until 14/09/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 03/06/2008 and displayed until 27/08/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 04/04/2008 and displayed until 03/06/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to Marketing Authorisation Holder
  • Change to MA holder contact details
Updated on 01/08/2006 and displayed until 04/04/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 18/07/2001 and displayed until 01/08/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   dopexamine hydrochloride